Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients With locally advanced colon cancerALLEGRA, Carmen J; PARR, Allyson L; KUGLER, John W et al.Journal of clinical oncology. 2002, Vol 20, Num 7, pp 1735-1743, issn 0732-183XArticle

Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinibEBERHARD, David A; JOHNSON, Bruce E; KLEIN, Pam et al.Journal of clinical oncology. 2005, Vol 23, Num 25, pp 5900-5909, issn 0732-183X, 10 p.Article

TRIBUTA: A phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancerHERBST, Roy S; PRAGER, Diane; RAMIES, David et al.Journal of clinical oncology. 2005, Vol 23, Num 25, pp 5892-5899, issn 0732-183X, 8 p.Article